AMEUF 11.76 Anteris Technologies Ltd
| Range: | 6.75-15.53 | Vol Avg: | 2853 | Last Div: | 0 | Changes: | 0.1 |
| Beta: | 0.71 | Cap: | 0.17B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Mon Dec 09 2013 | Empoloyees: | |||
| CUSIP: | CIK: | ISIN: | AU0000088841 | Country: | AU | ||
| CEO: | Mr. Wayne Geoffrey Paterson | Website: | https://www.anteristech.com | ||||
Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow